Yury I Miller Selected Research

Yury I Miller Research Topics

Disease

39	Atherosclerosis 01/2020 - 01/2003
24	Inflammation (Inflammations) 01/2021 - 11/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2005
6	Hypercholesterolemia 01/2018 - 04/2009
5	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2010
4	Neuroinflammatory Diseases 01/2021 - 01/2018
4	Pain (Aches) 01/2020 - 01/2018
3	Hypertriglyceridemia 01/2018 - 08/2015
2	Rupture 01/2021 - 01/2010
2	Hyperalgesia 01/2021 - 01/2018
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2020
2	Pathologic Processes 01/2020 - 10/2012
2	Rheumatoid Arthritis 01/2020 - 11/2012
2	Neoplasms (Cancer) 01/2020 - 01/2018
2	Acute Lung Injury 01/2020 - 01/2019
2	Infections 01/2020 - 01/2020
2	Fatty Liver 01/2018 - 01/2014
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017 - 01/2011
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2017 - 04/2016
2	Thrombosis (Thrombus) 05/2014 - 10/2013
2	Myocardial Infarction 01/2010 - 04/2009
2	Stroke (Strokes) 01/2010 - 04/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	COVID-19 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Glucose Intolerance 01/2018
1	Weight Gain 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Lung Injury 01/2018
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Costello Syndrome 01/2017
1	Pancreatitis 08/2015
1	Xanthomatosis (Xanthoma) 08/2015
1	Autoimmune Diseases (Autoimmune Disease) 11/2012

Drug/Important Bio-Agent (IBA)

22	LipidsIBA 01/2021 - 12/2004
16	oxidized low density lipoproteinIBA 01/2021 - 10/2003
16	Lipoproteins (Lipoprotein)IBA 11/2017 - 09/2005
12	CholesterolIBA 01/2021 - 04/2009
6	LDL Lipoproteins (beta Lipoproteins)IBA 05/2014 - 12/2004
4	EpitopesIBA 01/2019 - 05/2009
4	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2012
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 11/2005
4	AntibodiesIBA 10/2013 - 07/2005
3	LipopolysaccharidesIBA 01/2019 - 07/2010
3	1-penicillamyl-Leu(2)- oxytocinIBA 01/2018 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
3	Cholesterol Esters (Cholesteryl Esters)IBA 04/2017 - 01/2011
3	ChemokinesIBA 05/2014 - 09/2009
3	CytokinesIBA 09/2012 - 11/2005
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2013
2	Apolipoprotein C-II (ApoC2)IBA 01/2017 - 08/2015
2	Pattern Recognition ReceptorsIBA 01/2017 - 01/2011
2	Pharmaceutical PreparationsIBA 04/2016 - 01/2012
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2014 - 09/2009
2	AntigensIBA 10/2013 - 09/2012
2	LigandsIBA 11/2012 - 11/2005
2	C-Reactive ProteinIBA 01/2011 - 10/2003
1	SolutionsIBA 01/2020
1	Opiate AlkaloidsIBA 10/2018
1	Opioid Analgesics (Opioids)IBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	Single-Chain AntibodiesIBA 01/2018
1	LDL Receptors (LDL Receptor)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Surface-Active Agents (Surfactants)IBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2017
1	ApolipoproteinsIBA 11/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	Fibric Acids (Fibrates)IBA 04/2016
1	ISIS 304801IBA 04/2016
1	Peptides (Polypeptides)IBA 08/2015
1	Lipase (Acid Lipase)FDA Link 08/2015
1	InflammasomesIBA 03/2015
1	locked nucleic acidIBA 03/2015
1	Angiotensin IIIBA 03/2015
1	TOR Serine-Threonine KinasesIBA 05/2014
1	Sirolimus (Rapamycin)FDA Link 05/2014
1	EicosanoidsIBA 01/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2014
1	PlasminogenIBA 10/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2013
1	fostamatinibIBA 11/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2012
1	Biological ProductsIBA 10/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2011
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Spinal Injections 01/2018
1	Injections 01/2018